Breaking News Instant updates and real-time market news.

MU

Micron

$20.58

-0.07 (-0.34%)

, SUN

Sunoco

$25.15

1.61 (6.84%)

10:18
12/22/16
12/22
10:18
12/22/16
10:18

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Micron (MU) was upgraded to Buy from Hold at Cross Research, to Buy from Underperform at Needham, and to Buy from Hold at Summit Redstone. 2. Sunoco (SUN) upgraded to Outperform from Market Perform at FBR Capital with analyst Robert Balsamo saying the credit facility amendments announced reduce the need for a distribution cut. The analyst has a $32 price target for the shares. 3. National Instruments (NATI) upgraded to Outperform from Neutral at Baird with analyst Richard Eastman saying he sees the potential for accelerating revenue growth over the next few years combined with more determined focus to deliver operating leverage. 4. Merus (MRUS) upgraded to Buy from Neutral at Citi with analyst Yigal Nochomovitz saying the Incyte (INCY) collaboration deal has "very favorable" terms. 5. Sucampo (SCMP) upgraded to Buy from Neutral at Mizuho with the firm citing the sell-off in shares post the $260M convertible raise. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MU

Micron

$20.58

-0.07 (-0.34%)

SUN

Sunoco

$25.15

1.61 (6.84%)

NATI

National Instruments

$30.06

-0.14 (-0.46%)

MRUS

Merus

$20.22

6.07 (42.90%)

SCMP

Sucampo

$12.85

-0.425 (-3.20%)

MU Micron
$20.58

-0.07 (-0.34%)

12/22/16
CRSS
12/22/16
UPGRADE
CRSS
Buy
Micron upgraded to Buy from Hold at Cross Research
12/22/16
12/22/16
UPGRADE
Target $33

Buy
Micron upgraded to Buy after results at Needham
As previously reported, Needham analyst Rajvindra Gill upgraded Micron to Buy from Underperform, with a $33 price target, following the company's "significant beat and raise" this quarter. The analyst believes Micron has regained its customer positioning in 20nm, is successfully migrating to 3D NAND and is benefiting from a substantially better pricing environment in DRAM.
12/22/16
CHLM
12/22/16
NO CHANGE
CHLM
Micron report positive for Silicon Motion, says Craig-Hallum
Craig-Hallum analyst Tony Stoss said Micron's (MU) positive report highlighted strong demand it its SSD business. Stoss believes this is a positive for Silicon Motion (SIMO) as Micron uses its controller in their SSDs. Stoss rates Silicon Motion a Buy.
12/22/16
EVER
12/22/16
NO CHANGE
Target $30
EVER
Buy
Micron price target raised to $30 from $25 at Evercore ISI
SUN Sunoco
$25.15

1.61 (6.84%)

12/21/16
FBCO
12/21/16
UPGRADE
FBCO
Outperform
Sunoco upgraded on valuation, likely financing/deleveraging at Credit Suisse
As previously reported, Credit Suisse upgraded Sunoco (SUN) to Outperform from Neutral with a $31 price target. Analyst John Edwards said valuation is "underappreciated" and said a dividend cut is unlikely given options available for Sunoco and Energy Transfer Equity (ETE) to execute before reducing payouts.
12/22/16
12/22/16
UPGRADE
Target $32

Outperform
Sunoco upgraded to Outperform from Market Perform at FBR Capital
FBR Capital analyst Robert Balsamo upgraded Sunoco to Outperform saying the credit facility amendments announced last night reduce the need for a distribution cut. The analyst has a $32 price target for the shares.
12/21/16
FBCO
12/21/16
UPGRADE
FBCO
Outperform
Sunoco upgraded to Outperform from Neutral at Credit Suisse
12/21/16
12/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sunoco (SUN) upgraded to Outperform from Neutral at Credit Suisse with analyst John Edwards saying valuation is "underappreciated" and said a dividend cut is unlikely given options available for Sunoco and Energy Transfer Equity (ETE) to execute before reducing payouts. 2. BP (BP) and Statoil (STO) were upgraded to Buy from Neutral at UBS. 3. Citi (C) and Bank of America (BAC) were upgraded to Overweight from Neutral at Atlantic Equities while Morgan Stanley (MS) was upgraded to Neutral from Underweight. 4. Air Products (APD) upgraded to Buy from Neutral at Monness Crespi with the firm saying it thinks that Air Products will benefit from consolidation in the industry. It says that Air Products' balance sheet will enable it to "easily bid on and win new projects" and exploit divestitures in the sector. 5. Monster Beverage (MNST) upgraded to Buy from Hold at Jefferies with analyst Kevin Grundy calling the stock his top large cap growth pick in Consumer Products. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NATI National Instruments
$30.06

-0.14 (-0.46%)

12/22/16
BARD
12/22/16
UPGRADE
Target $35
BARD
Outperform
National Instruments upgraded to Outperform at Baird
As previously reported, Baird analyst Richard Eastman upgraded National Instruments to Outperform from Neutral. The analyst sees the potential for accelerating revenue growth over the next few years combined with more determined focus to deliver operating leverage. Eastman raised his price target to $35 from $32 on National Instrument shares.
04/05/16
STFL
04/05/16
NO CHANGE
STFL
National Instruments outlook still positive despite preannouncement, says Stifel
After National Instruments said that it expects its Q1 financial results to miss its previous guidance, Stifel says that the company should continue to gain T&M market share, while its gross margin is "sustainable at current levels." Stifel trimmed its price target on the name to $33 from $36 but keeps a Buy rating on the shares.
05/11/16
05/11/16
INITIATION
Target $28

Market Perform
National Instruments initiated with a Market Perform at FBR Capital
FBR Capital started National Instruments with a Market Perform rating and $28 price target.
12/22/16
BARD
12/22/16
UPGRADE
BARD
Outperform
National Instruments upgraded to Outperform from Neutral at Baird
MRUS Merus
$20.22

6.07 (42.90%)

12/22/16
SBSH
12/22/16
UPGRADE
Target $26
SBSH
Buy
Merus upgraded to Buy from Neutral at Citi
Citi analyst Yigal Nochomovitz upgraded Merus (MRUS) to Buy saying the Incyte (INCY) collaboration deal has "very favorable" terms. The deal with a "high-profile" company coupled with a $200M upfront payment "should meaningfully increase Street visibility," Nochomovitz tells investors in a research note. He raised his price target for Merus shares to $26 from $19. The stock closed yesterday up 43% to $20.22.
12/21/16
WEDB
12/21/16
NO CHANGE
Target $32
WEDB
Outperform
Merus price target rasied to $32 from $16 at Wedbush
11/07/16
SBSH
11/07/16
DOWNGRADE
Target $19
SBSH
Neutral
Merus downgraded to Neutral from Buy at Citi
Citi analyst Yigal Nochomovitz downgraded Merus to Neutral citing valuation with the stock up 100% in the last two months. The analyst sees a less favorable risk/reward into the year-end data for lead breast cancer drug MCLA-128. He raised his price target for the shares to $19 from $14.
12/21/16
JEFF
12/21/16
NO CHANGE
Target $29
JEFF
Buy
Jefferies ups Merus target to $29 after Incyte collaboration
Jefferies analyst Brian Abrahams views today's announced bispecific collaboration between Merus (MRUS) and Incyte (INCY) as a win for Merus. The deal provides "capital flexibility and strong validation" of the company's platform, while enabling maintenance of full rights to its clinical programs, Abrahams tells investors in a research note. He raised his price target for Merus shares to $29 from $21 and keeps a Buy rating on the name. The stock is up 45%, or $6.30, to $20.45 in midday trading.
SCMP Sucampo
$12.85

-0.425 (-3.20%)

08/04/16
MZHO
08/04/16
DOWNGRADE
MZHO
Neutral
Sucampo downgraded to Neutral from Buy at Mizuho
09/07/16
NORL
09/07/16
INITIATION
Target $15
NORL
Outperform
Sucampo initiated with an Outperform at Northland
Northland initiated Sucampo with an Outperform and $15 price target.
09/12/16
ROTH
09/12/16
NO CHANGE
Target $29
ROTH
Buy
Sucampo near-term Phase 3 events offer entry point, says Roth Capital
Roth Capital analyst Michael Higgins believes investors are overlooking the revenue/risk potential from Sucampo's two near-term Phase 3 events. The analyst disagrees with the "no pipeline" and "mature product" impressions, especially considering the outlook for Amitiza in a Phase 3 in 6-17 year olds with constipation. Higgins reiterates a Buy rating and $29 price target on the shares.
12/22/16
MZHO
12/22/16
UPGRADE
MZHO
Buy
Sucampo upgraded to Buy from Neutral at Mizuho
Mizuho upgraded Sucampo to Buy with a $16 price target citing the sell-off in shares post the $260M convertible raise.

TODAY'S FREE FLY STORIES

RELY

Real Industry

$0.52

0.1643 (45.92%)

17:38
11/20/17
11/20
17:38
11/20/17
17:38
Hot Stocks
Real Industry, Real Alloy receive court approval of 'first day' motions »

Real Industry announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAVN

Raven

$34.65

0.85 (2.51%)

17:34
11/20/17
11/20
17:34
11/20/17
17:34
Earnings
Raven reports Q3 EPS 33c, consensus 23c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ONTX

Onconova

$1.70

0.01 (0.59%)

17:34
11/20/17
11/20
17:34
11/20/17
17:34
Syndicate
Breaking Syndicate news story on Onconova »

Onconova files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ONTX

Onconova

$1.70

0.01 (0.59%)

17:33
11/20/17
11/20
17:33
11/20/17
17:33
Syndicate
Breaking Syndicate news story on Onconova »

Onconova files $84.55M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

MLNX

Mellanox

$51.05

1 (2.00%)

17:31
11/20/17
11/20
17:31
11/20/17
17:31
Hot Stocks
Starboard Value reports 9.8% stake in Mellanox »

Starboard has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 05

    Dec

  • 06

    Dec

ASYS

Amtech Systems

$14.12

0.93 (7.05%)

, PANW

Palo Alto Networks

$142.53

-0.19 (-0.13%)

17:27
11/20/17
11/20
17:27
11/20/17
17:27
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Amtech…

ASYS

Amtech Systems

$14.12

0.93 (7.05%)

PANW

Palo Alto Networks

$142.53

-0.19 (-0.13%)

URBN

Urban Outfitters

$28.27

0.37 (1.33%)

CLSN

Celsion

$2.14

0.14 (7.00%)

SNSS

Sunesis

$2.87

0.01 (0.35%)

HAIN

Hain Celestial

$40.89

1.05 (2.64%)

NSRGY

Nestle

$85.14

0.03 (0.04%)

A

Agilent

$69.96

1.17 (1.70%)

BECN

Beacon Roofing

$56.28

0.65 (1.17%)

INTU

Intuit

$157.78

1.23 (0.79%)

SNCR

Synchronoss

$11.14

0.76 (7.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 30

    Nov

  • 11

    Dec

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

SNGX

Soligenix

$2.24

0.02 (0.90%)

17:23
11/20/17
11/20
17:23
11/20/17
17:23
Syndicate
Breaking Syndicate news story on Soligenix »

Soligenix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTIB

CTI Industries

$3.56

-0.269 (-7.03%)

17:23
11/20/17
11/20
17:23
11/20/17
17:23
Hot Stocks
CTI Industries names Frank Cesario CFO »

CTI Industries announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEDG

SolarEdge

$38.90

1.35 (3.60%)

17:22
11/20/17
11/20
17:22
11/20/17
17:22
Hot Stocks
SolarEdge chairman, CEO Sella diagnosed with colon cancer »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

STLY

Stanley Furniture

$0.93

0.0349 (3.92%)

17:20
11/20/17
11/20
17:20
11/20/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Stanley Furniture »

Stanley Furniture trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLAD

Gladstone Capital

$9.76

-0.02 (-0.20%)

17:09
11/20/17
11/20
17:09
11/20/17
17:09
Earnings
Gladstone Capital reports Q4 NII 21c, consensus 21c »

Reports NAV per share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

T

AT&T

$34.64

0.13 (0.38%)

, TWX

Time Warner

$87.71

-1.01 (-1.14%)

17:07
11/20/17
11/20
17:07
11/20/17
17:07
Hot Stocks
Breaking Hot Stocks news story on AT&T, Time Warner »

Department of Justice…

T

AT&T

$34.64

0.13 (0.38%)

TWX

Time Warner

$87.71

-1.01 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

LMT

Lockheed Martin

$314.65

4.95 (1.60%)

17:07
11/20/17
11/20
17:07
11/20/17
17:07
Hot Stocks
Lockheed Martin awarded $122.3M U.S. Navy contract »

ockheed Martin Rotary and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

ZTO

ZTO Express

$17.00

0.17 (1.01%)

17:02
11/20/17
11/20
17:02
11/20/17
17:02
Earnings
Breaking Earnings news story on ZTO Express »

ZTO Express sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MSG

Madison Square Garden

$215.00

-3.46 (-1.58%)

17:01
11/20/17
11/20
17:01
11/20/17
17:01
Hot Stocks
Madison Square Garden acquires Obscura Digital, terms not disclosed »

The Madison Square Garden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTO

ZTO Express

$17.00

0.17 (1.01%)

17:01
11/20/17
11/20
17:01
11/20/17
17:01
Earnings
ZTO Express reports Q3 EPS 15c, consensus 15c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

VICL

Vical

$1.98

0.04 (2.06%)

16:59
11/20/17
11/20
16:59
11/20/17
16:59
Hot Stocks
Breaking Hot Stocks news story on Vical »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BECN

Beacon Roofing

$56.28

0.65 (1.17%)

16:57
11/20/17
11/20
16:57
11/20/17
16:57
Earnings
Beacon Roofing sees FY18 adjusted EPS $2.95-$3.25, consensus $2.57 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

ABC

AmerisourceBergen

$77.46

-1.38 (-1.75%)

16:56
11/20/17
11/20
16:56
11/20/17
16:56
Earnings
AmerisourceBergen sees FY18 revenue up 8%-11% following H.D. Smith acquisition »

Consensus $164.76B. Based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 29

    Nov

ABC

AmerisourceBergen

$77.46

-1.38 (-1.75%)

16:53
11/20/17
11/20
16:53
11/20/17
16:53
Hot Stocks
AmerisourceBergen to acquire H.D. Smith for $815M in cash »

AmerisourceBergen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 29

    Nov

RGEN

Repligen

$33.26

-0.14 (-0.42%)

16:53
11/20/17
11/20
16:53
11/20/17
16:53
Conference/Events
Repligen management to meet with Stephens »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

BKI

Black Knight

$45.80

0.3 (0.66%)

16:51
11/20/17
11/20
16:51
11/20/17
16:51
Syndicate
Black Knight files to sell 5M shares of common stock for holders »

Goldman Sachs & Co. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SASR

Sandy Spring Bancorp

$38.94

-0.06 (-0.15%)

16:51
11/20/17
11/20
16:51
11/20/17
16:51
Conference/Events
Sandy Spring Bancorp management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLY

Stanley Furniture

$0.93

0.0349 (3.92%)

, CHDN

Churchill Downs

$217.15

-0.65 (-0.30%)

16:51
11/20/17
11/20
16:51
11/20/17
16:51
Hot Stocks
Stanley Furniture to sell substantially all its assets to Churchill Downs »

Stanley Furniture Company…

STLY

Stanley Furniture

$0.93

0.0349 (3.92%)

CHDN

Churchill Downs

$217.15

-0.65 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YRCW

YRC Worldwide

$11.21

0.39 (3.60%)

16:49
11/20/17
11/20
16:49
11/20/17
16:49
Conference/Events
YRC Worldwide management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 28

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.